Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lutropin Alfa for Embryo Quality in Advanced Reproductive Age
NCT01075815Phase 2Terminated
- Sponsor
- Merck KGaA
- Start
- Nov 2008
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lutropin alfa in infertility (2 arms), sponsored by Merck KGaA. Primary endpoint: Implantation Rate. Started Nov 2008; status: terminated.
02
Drugs
lutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01075815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01075815.